Robert Paul Harris serves as Executive at Tribute Pharmaceuticals Canada Inc., where they oversee executive responsibilities. Since joining the company, Robert Paul Harris has executed 11 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 11, 2017 involved receiving (via award) 7,500 shares valued at $0.
Robert Paul Harris currently holds 601,594 shares of Tribute Pharmaceuticals Canada Inc. (TBUFF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Paul Harris has been a net seller of TBUFF stock. They have purchased $866.0K and sold $1.5M worth of shares.
Robert Paul Harris's most recent insider trade was on May 11, 2017, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.92 |
| Discretionary |
| Nov 29, 2016 | ARLZ | $522.8K | Sale | 104,778 | $4.99 | Discretionary |
| Nov 28, 2016 | ARLZ | $78.4K | Option Exercise | 20,000 | $3.92 | Discretionary |
| Nov 28, 2016 | ARLZ | $93.0K | Sale | 20,000 | $4.65 | Discretionary |
| Sep 15, 2016 | ARLZ | $420.0K | Sale | 75,000 | $5.60 | Discretionary |
| Sep 15, 2016 | ARLZ | $453.0K | Sale | 75,000 | $6.04 | Discretionary |
| Jun 16, 2016 | ARLZ | $0 | Award | 7,500 | $N/A | Discretionary |
| Feb 27, 2013 | TBUFF | $250.0K | Purchase | 625,000 | $0.40 | Discretionary |
| Mar 22, 2012 | TBUFF | $308.0K | Purchase | 550,000 | $0.56 | Discretionary |
| Mar 22, 2012 | TBUFF | $308.0K | Purchase | 550,000 | $0.56 | Discretionary |